Neurodegenerative disorders like Alzheimer’s, Parkinson’s, and dementia are increasing globally due to limited long-term treatments. This review highlights the neuroprotective potential of Salvinia species, aquatic ferns rich in bioactive compounds such as flavonoids, alkaloids, and phenolics. These phytochemicals exhibit antioxidant, anti-inflammatory, neurotransmitter-modulating, and mitochondrialprotective activities. The review critically examines their role in targeting key pathological features like β-amyloid accumulation, tau destabilization, and dopaminergic neuron loss. While in vitro and in vivo results are promising, further pharmacological and clinical studies are essential to validate Salvinia as a potential source of therapeutic agents for cognitive disorders.
Building similarity graph...
Analyzing shared references across papers
Loading...
Urja V. Chaudhari
Blessy Jacob
D. Visagaperumal
International Journal of Newgen Research in Pharmacy & Healthcare
Building similarity graph...
Analyzing shared references across papers
Loading...
Chaudhari et al. (Fri,) studied this question.
www.synapsesocial.com/papers/68c1ad4f54b1d3bfb60e4d33 — DOI: https://doi.org/10.61554/ijnrph.v3i1.2025.144
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: